Cinnamaldehydes inhibit thioredoxin reductase and induce Nrf2: potential candidates for cancer therapy and chemoprevention

Gromer, 2004, The thioredoxin system—from science to clinic, Med. Res. Rev., 24, 40, 10.1002/med.10051

Lillig, 2007, Thioredoxin and related molecules—from biology to health and disease, Antioxid. Redox. Signaling, 9, 25, 10.1089/ars.2007.9.25

Soini, 2001, Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma, Clin. Cancer Res., 7, 1750

Kahlos, 2001, Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma, Int. J. Cancer, 95, 198, 10.1002/1097-0215(20010520)95:3<198::AID-IJC1034>3.0.CO;2-F

Kim, 2005, High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer, Clin. Cancer Res., 11, 8425, 10.1158/1078-0432.CCR-05-0449

Raffel, 2003, Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival, J. Lab. Clin. Med., 142, 46, 10.1016/S0022-2143(03)00068-4

Yoo, 2006, Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells, J. Biol. Chem., 281, 13005, 10.1074/jbc.C600012200

Williams, 1992, Lipoamide dehydrogenase, glutathione reductase, thioredoxin reductase, and mercuric ion reductase—a family of flavoenzyme transhydrogenases, Vol. 3, 121

Papp, 2007, From selenium to selenoproteins: synthesis, identity, and their role in human health, Antioxid. Redox Signaling, 9, 775, 10.1089/ars.2007.1528

Sandalova, 2001, Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme, Proc. Natl. Acad. Sci. USA, 98, 9533, 10.1073/pnas.171178698

Biterova, 2005, Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism, Proc. Natl. Acad. Sci. USA, 102, 15018, 10.1073/pnas.0504218102

Fritz-Wolf, 2007, The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis, J. Mol. Biol., 370, 116, 10.1016/j.jmb.2007.04.044

Urig, 2006, On the potential of thioredoxin reductase inhibitors for cancer therapy, Semin. Cancer Biol., 16, 452, 10.1016/j.semcancer.2006.09.004

Lu, 2007, Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide, Proc. Natl. Acad. Sci. USA, 104, 12288, 10.1073/pnas.0701549104

Chew, 2008, Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity, FASEB J., 22, 2072, 10.1096/fj.07-101477

Brigelius-Flohé, 2006, Part of the series: from dietary antioxidants to regulators in cellular signaling and gene regulation. Sulforaphane and selenium, partners in adaptive response and prevention of cancer, Free Radic. Res., 40, 775, 10.1080/10715760600722643

Rushmore, 1991, The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity, J. Biol. Chem., 266, 11632, 10.1016/S0021-9258(18)99004-6

Ramos-Gomez, 2001, Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice, Proc. Natl. Acad. Sci. USA, 98, 3410, 10.1073/pnas.051618798

Zhang, 2006, Mechanistic studies of the Nrf2–Keap1 signaling pathway, Drug Metab. Rev., 38, 769, 10.1080/03602530600971974

Li, 2009, Molecular mechanisms of Nrf2-mediated antioxidant response, Mol. Carcinog., 48, 91, 10.1002/mc.20465

Dinkova-Kostova, 2005, The role of Keap1 in cellular protective responses, Chem. Res. Toxicol., 18, 1779, 10.1021/tx050217c

Fang, 2005, Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity, J. Biol. Chem., 280, 25284, 10.1074/jbc.M414645200

Lu, 2006, Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity, Cancer Res., 66, 4410, 10.1158/0008-5472.CAN-05-3310

Talalay, 1988, Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis, Proc. Natl. Acad. Sci. USA, 85, 8261, 10.1073/pnas.85.21.8261

Dinkova-Kostova, 2001, Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups, Proc. Natl. Acad. Sci. USA, 98, 3404, 10.1073/pnas.051632198

Arnér, 1999, High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes, J. Mol. Biol., 292, 1003, 10.1006/jmbi.1999.3085

Jeong, 2000, Cinnamaldehydes inhibit cyclin dependent kinase 4/cyclin D1, Bioorg. Med. Chem. Lett., 10, 1819, 10.1016/S0960-894X(00)00357-7

Arner, 2000, Measurement of thioredoxin and thioredoxin reductase, 7.4.1

Dhakshinamoorthy, 2004, Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells, J. Biol. Chem., 279, 20096, 10.1074/jbc.M312492200

Han, 2004, 2′-Benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species, J. Biol. Chem., 279, 6911, 10.1074/jbc.M309708200

Wu, 2007, MAPK inhibitors and pifithrin-alpha block cinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells, Food Chem. Toxicol., 45, 2446, 10.1016/j.fct.2007.05.032

Cenas, 2004, Interactions of quinones with thioredoxin reductase: a challenge to the antioxidant role of the mammalian selenoprotein, J. Biol. Chem., 279, 2583, 10.1074/jbc.M310292200

Gasdaska, 1995, Cloning and sequencing of a human thioredoxin reductase, FEBS Lett., 373, 5, 10.1016/0014-5793(95)01003-W

Zhong, 2000, Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine–selenocysteine sequence, Proc. Natl. Acad. Sci. USA, 97, 5854, 10.1073/pnas.100114897

Arscott, 1997, The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli, Proc. Natl. Acad. Sci. USA, 94, 3621, 10.1073/pnas.94.8.3621

Hintze, 2003, Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element, J. Nutr., 133, 2721, 10.1093/jn/133.9.2721

Chen, 2005, 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2, J. Biol. Chem., 280, 41921, 10.1074/jbc.M508556200

Liao, 2008, Cinnamaldehyde inhibits the tumor necrosis factor-alpha-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2, Toxicol. Appl. Pharmacol., 229, 161, 10.1016/j.taap.2008.01.021

Wondrak, 2008, Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress, Free Radic. Biol. Med., 45, 385, 10.1016/j.freeradbiomed.2008.04.023

Masutani, 2009, Fragrant unsaturated aldehydes elicit activation of the Keap1/Nrf2 System leading to the up-regulation of thioredoxin expression and protection against oxidative stress, Antioxid. Redox. Signaling, 11, 949, 10.1089/ars.2008.2292

Ka, 2003, Cinnamaldehyde induces apoptosis by ROS-mediated mitochondrial permeability transition in human promyelocytic leukemia HL-60 cells, Cancer Lett., 196, 143, 10.1016/S0304-3835(03)00238-6

Lee, 1999, Inhibition of human tumor growth by 2′-hydroxy- and 2′-benzoyloxycinnamaldehydes, Planta. Med., 65, 263, 10.1055/s-2006-960772

Kwon, 1996, 2′-Hydroxycinnamaldehyde from stem bark of Cinnamomum cassia, Planta. Med., 62, 183, 10.1055/s-2006-957851

Kwon, 1997, Synthesis and biological activity of cinnamaldehydes as angiogenesis inhibitors, Bioorg. Med. Chem. Lett., 7, 2473, 10.1016/S0960-894X(97)10008-7

Moon, 2006, Delayed occurrence of H-ras12V-induced hepatocellular carcinoma with long-term treatment with cinnamaldehydes, Eur. J. Pharmacol., 530, 270, 10.1016/j.ejphar.2005.11.053

Kwon, 1998, Synthesis and in vitro cytotoxicity of cinnamaldehydes to human solid tumor cells, Arch. Pharmacal. Res., 21, 147, 10.1007/BF02974019

Kim, 2004, Physicochemical properties of 2′-benzoyloxycinnamaldehyde, Int. J. Pharm., 287, 21, 10.1016/j.ijpharm.2004.08.011

Lee, 2009, Plasma pharmacokinetics and metabolism of the antitumour drug candidate 2′-benzoyloxycinnamaldehyde in rats, Xenobiotica, 39, 255, 10.1080/00498250802650069

Hong, 2007, Apoptosis induction of 2′-hydroxycinnamaldehyde as a proteasome inhibitor is associated with ER stress and mitochondrial perturbation in cancer cells, Biochem. Pharmacol., 74, 557, 10.1016/j.bcp.2007.05.016

Park, 2005, Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells, Biochem. Biophys. Res. Commun., 327, 1058, 10.1016/j.bbrc.2004.12.104